Alap: ISHNUSBI
iShares Nasdaq US Biotechnology UCITS ETF USD | |
IE00BYXG2H39 | |
19.10.2017 | |
Equity | |
Részvény Sectors - Health Care | |
BlackRock iShares | |
BlackRock Advisors (UK) Limited | |
USD | |
1 000 | |
5% |
1M | 3M | 6M | 9M | 1R | 3R p.a. | 5R p.a. | 7R p.a. | 10R p.a. | od vnizku p.a. | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Výkonnosť fondu | 1.20% | 3.33% | 7.16% | 10.71% | 6.67% | -3.22% | 7.15% | - | - | N/A | |
Priemerná výkonnosť (36 meraní) | -0.07% | -1.35% | 4.43% | - | - | ||||||
Volatilita od priemernej výkonnosti | 8.32% | 24.80% | 9.70% | - | - |
Long | Short | Net | |
---|---|---|---|
Részvény | 99.47% | 99.47% | |
Kötvény | 0.00% | 0.00% | |
Other | |||
Pénz piac | 0.53% | 0.53% |
Aktíva | 4 760 mil. |
Počet akcíí | 215 |
Počet dlhopisov | 0 |
Priebež. popl. | 0.35 |
z toho Mng. popl. | 0.35 |
Výk. prémia | |
Trans. popl. |
Dividenda | |
Dividendový výnos | |
Rozhodný dátum | |
Frekvencia výplaty |
Giant | 6.06% |
Large | 39.75% |
Medium | 21.31% |
Small | 16.21% |
Micro | 13.14% |
P/E | 17.01% |
P/BV | 3.21% |
Healthcare | 99.47% |
Government | 0.00 |
Corporate | 0.00 |
Derivatives | 0.53 |
Výnos do splatnosti p.a. | |
Modifikovaná durácia |
AAA | 0.00 |
AA | 0.97 |
A | 0.00 |
BBB | 0.00 |
BB | 0.00 |
B | 0.00 |
Below B | 0.00 |
Not Rated | 99.03 |
United States | 87.56% |
Canada | 0.40% |
Latin America | |
United Kingdom | 6.08% |
Eurozone | 3.03% |
Europe - ex Euro | 1.46% |
Europe - Emerging | |
Africa | |
Middle East | |
Japan | |
Australasia | |
Asia - Developed | 0.14% |
Asia - Emerging | 0.80% |
Emerging Market | 0.80% |
Developed Country | 98.66% |
Not Classified |
Spoločnosť | Subsektor | Váha | Spoločnosť | Subsektor | Váha |
---|---|---|---|---|---|
Vertex Pharmaceuticals Inc | Healthcare | 8.97% | Amgen Inc | Healthcare | 8.72% |
Regeneron Pharmaceuticals Inc | Healthcare | 8.44% | Gilead Sciences Inc | Healthcare | 7.08% |
Moderna Inc | Healthcare | 5.72% | AstraZeneca PLC ADR | Healthcare | 4.72% |
Biogen Inc | Healthcare | 3.4% | Alnylam Pharmaceuticals Inc | Healthcare | 2.03% |
Illumina Inc | Healthcare | 1.74% | Biomarin Pharmaceutical Inc | Healthcare | 1.61% |